NCT06022068View on ClinicalTrials.gov

Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

December 11, 2024

Study Completion Date

January 17, 2025

Conditions
Alzheimer Disease
Interventions
DRUG

Sirolimus

7 mg taken once per week during 26 weeks.

Trial Locations (1)

171 64

Karolinska University Hospital Memory clinic, Solna

All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

lead

Karolinska Institutet

OTHER

NCT06022068 - Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography | Biotech Hunter | Biotech Hunter